Literature DB >> 8757619

Identification of a novel regulatory region critical for expression of the RANTES chemokine in activated T lymphocytes.

P J Nelson1, B D Ortiz, J M Pattison, A M Krensky.   

Abstract

The RANTES chemokine is a T cell-expressed, proinflammatory cytokine recently implicated as a suppressive agent of HIV replication. We have identified tandem kappaB-like sequences within the promoter for RANTES that are critical for RANTES promoter-reporter gene activity in both the T cell tumor line Hut78 and in PHA-activated PBL. This region binds not only Rel family members (including p50-p65 heterodimers and p50-p50 homodimers) but also non-Rel factors up-regulated in PBL 3 to 5 days following activation. The expression of these "late" expressed nuclear factors correlates with an up-regulation of RANTES message found at this point in T cell activation. These factors are also constitutively expressed in functionally mature CD8+ T cells. We hypothesize that these apparently novel proteins are responsible in part for the temporal regulation of RANTES seen in peripheral blood T cells and represent a component of transcriptional regulatory machinery newly expressed at this "late" stage of peripheral T cell development.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8757619

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  Virus-inducible expression of a host chemokine gene relies on replication-linked mRNA stabilization.

Authors:  T Koga; E Sardiña; R M Tidwell; M Pelletier; D C Look; M J Holtzman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

2.  Essential role of interferon regulatory factor 3 in direct activation of RANTES chemokine transcription.

Authors:  R Lin; C Heylbroeck; P Genin; P M Pitha; J Hiscott
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

Review 3.  Chemokines: understanding their role in T-lymphocyte biology.

Authors:  S G Ward; J Westwick
Journal:  Biochem J       Date:  1998-08-01       Impact factor: 3.857

4.  Multiple cis regulatory elements control RANTES promoter activity in alveolar epithelial cells infected with respiratory syncytial virus.

Authors:  A Casola; R P Garofalo; H Haeberle; T F Elliott; R Lin; M Jamaluddin; A R Brasier
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

5.  Inhibition of cytokine gene expression by sodium salicylate in a macrophage cell line through an NF-kappaB-independent mechanism.

Authors:  S Lemay; T V Lebedeva; A K Singh
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

6.  Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression.

Authors:  H Liu; D Chao; E E Nakayama; H Taguchi; M Goto; X Xin; J K Takamatsu; H Saito; Y Ishikawa; T Akaza; T Juji; Y Takebe; T Ohishi; K Fukutake; Y Maruyama; S Yashiki; S Sonoda; T Nakamura; Y Nagai; A Iwamoto; T Shioda
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

7.  RANTES gene promoter polymorphisms are associated with bronchial hyperresponsiveness in Korean children with asthma.

Authors:  Myung Hyun Sohn; Seung-Hyun Kim; Kyung-Won Kim; Hye Mi Jee; Hae-Sim Park; Kyu-Earn Kim
Journal:  Lung       Date:  2007-11-08       Impact factor: 2.584

8.  Dynamic interplay of transcriptional machinery and chromatin regulates "late" expression of the chemokine RANTES in T lymphocytes.

Authors:  Yong-Tae Ahn; Boli Huang; Lisa McPherson; Carol Clayberger; Alan M Krensky
Journal:  Mol Cell Biol       Date:  2006-10-30       Impact factor: 4.272

9.  Association between regulated upon activation, normal T cells expressed and secreted (RANTES) -28C/G polymorphism and asthma risk--a meta-analysis.

Authors:  Qiaoqiao Fang; Furu Wang; Deyu Zhao
Journal:  Int J Med Sci       Date:  2010-02-10       Impact factor: 3.738

Review 10.  Chemokine/chemokine receptor-mediated inflammation regulates pathologic changes from acute kidney injury to chronic kidney disease.

Authors:  Kengo Furuichi; Shuichi Kaneko; Takashi Wada
Journal:  Clin Exp Nephrol       Date:  2008-12-16       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.